* Newlink Genetics awarded $25 million contract from BARDA
for investigational Ebola Zaire vaccine (V920)
Source text for Eikon:
Further company coverage:
The post BRIEF-Newlink Genetics awarded $25 mln contract from BARDA for investigational Ebola Zaire vaccine (V920) appeared first on NASDAQ.